Table 1 Demographic and clinical characteristics of study participants in two groups
Variables | Letrozole group (N = 34) | Control group (N = 30) | P value |
|---|---|---|---|
Female age (years) | \(31.38 \pm 5.06\) | \(33.41 \pm 4.51\) | 0.10 |
Body mass index (kg/m2) | \(21.9 \pm 2.2\) | \(21.5 \pm 2.4\) | 0.56 |
Duration of infertility (years) | \(2.2 \pm 2.34\) | \(3.7 \pm 3.5\) | 0.06 |
No. of couples with primary infertility, n (%) | 28 (82.4) | 22 (73.3) | 0.65 |
No. of women with dysmenorrhea, n (%) | 17 (50) | 16 (53.3) | 0.78 |
PCOS diagnosis, n (%) | 5 (14.7) | 4 (13.3) | 0.91 |
Endometriosis type, n (%) | |||
OMA | 24 (52.9) | 23 (76.7) | 0.528 |
DIE | 10 (47.1) | 7 (23.3) | |
Endometriosis stage, n (%) | |||
Stage III | 29 (85.3) | 28 (93.3) | 0.405 |
Stage IV | 5 (14.7) | 2 (6.7) | |
Basal serum level of FSH (IU/L) | \(4.0 \pm 2.2\) | \(4.9 \pm 2.4\) | 0.13 |
Basal serum level of LH (IU/L) | \(4.5 \pm 2.3\) | \(5.4 \pm 2.2\) | 0.11 |
Serum level of AMH (ng/ml) | \(2.4 \pm 1.1\) | \(2.1 \pm 1.5\) | 0.31 |
Serum level of TSH (IU/mL) | \(1.3 \pm 1.3\) | \(1.5 \pm 1.1\) | 0.52 |
Antral follicle count | \(7.3 \pm 2.1\) | \(6.9 \pm 3.1\) | 0.43 |
No. of previous failed IVF cycles | \(0.14 \pm 0.34\) | \(0.41 \pm 0.73\) | 0.10 |